1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Icon Bioscience Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) IBI-20089/Lucentis - Age-Related Macular Degeneration, Choroidal Neovascularization | Phase 1 / Phase 2 | Completed | University of Illinois at Chicago | 10 | 2010-09-01 | 2014-10-20 |
Choroidal Neovascularization (1) · Macular Degeneration (1)
Ranibizumab (1) · Triamcinolone Acetonide (1)
United States (1)